Introducing NEXEL’s Disease modeling
Disease Modeling with pluripotent stem cells without patient samples
NEXEL is undertaking an innovative research to develop in vitro efficacy and safety assays. One such assay is disease modeling where NEXEL’s iPSC-derived cell products will be used to mimic and represent the disease environment. In the near future, both the efficacy and safety profile of a drug candidate will easily be accessible early in the development stage.